Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?

Caocci, Giovanni
First
;
La Nasa, Giorgio
Last
2020-01-01

Files in This Item:
File Size Format  
Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS).pdf

Solo gestori archivio

Type: versione editoriale
Size 220.93 kB
Format Adobe PDF
220.93 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie